3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Waldenstrom Macroglobulinemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, Mantle-Cell
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Prolymphocytic, T-Cell
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Dexamethasone
4
Cyclophosphamide
4
Bortezomib
3
daratumumab
2
belantamab mafodotin
2
venetoclax
1
pegfilgrastim
1
ixazomib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Lenalidomide
1
Calcium Dobesilate
1
Antineoplastic Protocols
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Amyloidosis
×
Lisaftoclax
×
1 year
×
Clear all
No trials found.